Ligand Pharmaceuticals, Inc. (LGND)
220.95
+10.62
(+5.05%)
USD |
NASDAQ |
May 08, 16:00
221.31
+0.36
(+0.16%)
After-Hours: 19:25
Ligand Pharmaceuticals EPS Diluted (Quarterly) : 2.119 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| XOMA Royalty Corp. | 0.2586 |
| Amicus Therapeutics, Inc. (DELISTED) | 0.0054 |
| Johnson & Johnson | 2.141 |
| ADMA Biologics, Inc. | 0.2025 |
| Travere Therapeutics, Inc. | -0.3984 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 44.78M |
| Revenue (Quarterly) | 59.67M |
| Total Expenses (Quarterly) | 14.88M |
| Enterprise Value | 3.912B |
| Gross Profit Margin (Quarterly) | 81.42% |
| Profit Margin (Quarterly) | 75.06% |
| Earnings Yield | 2.64% |
| Operating Earnings Yield | 1.06% |
| Normalized Earnings Yield | 1.396 |